Development of Eosinophilic Fasciitis during Infliximab Therapy for Psoriatic Arthritis
Joint Authors
Hariman, Richard
Patel, Payal
Strouse, Jennifer
Collins, Michael P.
Rosenthal, Ann
Source
Issue
Vol. 2016, Issue 2016 (31 Dec. 2016), pp.1-4, 4 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2016-05-11
Country of Publication
Egypt
No. of Pages
4
Main Subjects
Abstract EN
Eosinophilic fasciitis (EF) is a rare disorder involving chronic inflammation of the fascia and connective tissue surrounding muscles, nerves, and blood vessels.
While its pathogenesis is not entirely understood, this disorder is thought to be autoimmune or allergic in nature.
We present here a case of a 59-year-old male who developed peripheral eosinophilia and subsequent eosinophilic fasciitis during treatment with infliximab.
To our knowledge, eosinophilic fasciitis has not been previously described in patients during treatment with an inhibitor of tumor necrosis factor α.
American Psychological Association (APA)
Hariman, Richard& Patel, Payal& Strouse, Jennifer& Collins, Michael P.& Rosenthal, Ann. 2016. Development of Eosinophilic Fasciitis during Infliximab Therapy for Psoriatic Arthritis. Case Reports in Rheumatology،Vol. 2016, no. 2016, pp.1-4.
https://search.emarefa.net/detail/BIM-1102667
Modern Language Association (MLA)
Hariman, Richard…[et al.]. Development of Eosinophilic Fasciitis during Infliximab Therapy for Psoriatic Arthritis. Case Reports in Rheumatology No. 2016 (2016), pp.1-4.
https://search.emarefa.net/detail/BIM-1102667
American Medical Association (AMA)
Hariman, Richard& Patel, Payal& Strouse, Jennifer& Collins, Michael P.& Rosenthal, Ann. Development of Eosinophilic Fasciitis during Infliximab Therapy for Psoriatic Arthritis. Case Reports in Rheumatology. 2016. Vol. 2016, no. 2016, pp.1-4.
https://search.emarefa.net/detail/BIM-1102667
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-1102667